Mitsui agreed with Oncoshot and Mitsui & Co stock fell 3.04 percent

Published on 10/08/2026 at 10:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mitsui & Co stock costs EUR 26.81 on October 8, 2026 versus EUR 27.65. First-quarter earnings reached JPY 294.05 billion.

Mitsui-Soko, JP3893600001, Illustration mit AI erstellt.

Mitsui & Co stock was trading at EUR 26.81 at Lang & Schwarz on October 8, 2026 at 10:10 a.m. CEST, down 3.04 percent versus the prior close of EUR 27.65. On September 13, 2026, Mitsui had entered a service agreement with Oncoshot on clinical data analysis technology, according to Markets Insider.

Clinical data adds a healthcare angle

The agreement links Oncoshot's artificial intelligence technology with the IHH Healthcare network and oncology specialists across the Asia-Pacific region. The stated aim is to structure real-world medical data while supporting international research, clinical development and knowledge exchange.

The initiative fits Mitsui's Wellness Ecosystem Creation 2.0 strategy under its Medium-term Management Plan 2029. For the conglomerate, the project connects an existing healthcare holding with a potential data-based service model rather than relying only on traditional trading activity.

First-quarter figures set the benchmark

For the first quarter of fiscal 2027, Mitsui reported revenue of JPY 4.35 trillion, earnings of JPY 294.05 billion and a profit margin of 6.76 percent, according to Yahoo Finance. GAAP earnings per share was JPY 103.73 versus a JPY 75.65 estimate, making the earnings comparison the clearest near-term measure of operating delivery.

The figures also give context to the October price move. The stock's euro indication fell 3.04 percent from EUR 27.65, while the latest reported quarter provides a quantified comparison between actual and expected earnings per share.

November results are the next marker

Mitsui's investor-relations page schedules the announcement of financial results for the six-month period ended September 30, 2026, for November 4, 2026, at 12:00 p.m. JST. The release will show whether first-quarter earnings performance carried into the first half and whether healthcare initiatives remain a supporting theme for the wider portfolio.

Stock trades below the prior close

The Lang & Schwarz price of EUR 26.81 was trading on October 8, 2026 at 10:10 a.m. CEST, down 3.04 percent versus the EUR 27.65 prior close of October 7, 2026. The primary listing is on the Tokyo Stock Exchange in JPY under ticker 8031, according to Global Banking & Finance. The further course of trading is shown by the continuously updated real-time quote of Mitsui & Co stock.